?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
496 Unternehmen gefunden • Seite 15 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | ARS Pharmaceuticals, Inc | 26.6 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 3.11 | 29.09 | ▲ 36.42% | ▲ 176.24% | - | - | - | -203.25% | ▲ 297.32% | -212.92% | ▲ 297.61% | -203.14% | ▲ 330.87% | 3 / 9 | −0,91 | −82,7-fach | 19 / 100 | −0,1 / 100 | −0,62 |
![]() | Supernus Pharmaceuticals Inc | 26.6 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | - | 129.67 | 2.93 | 2.36 | ▲ 6.68% | - | - | - | - | -5.36% | ▼ -2.71% | -5.13% | ▼ -3.45% | 6.40% | ▼ -2.19% | 5 / 9 | 5,17 | 22-fach | 44 / 100 | −5,9 / 100 | −2,43 |
| COSMO N NV | 26.6 | Arzneimittel (Pharmazeutisch) | Irland | 1.2 Mrd. USD | - | - | 10.24 | 1.85 | ▲ 11.46% | ▼ -14.40% | 3.46% | - | - | -3.46% | ▼ -4.05% | -10.00% | ▼ -2.58% | -15.12% | ▼ -0.95% | 3 / 9 | 7,50 | 18-fach | 8 / 100 | 1,3 / 100 | 0,13 | |
![]() | Ocular Therapeutix Inc | 26.6 | Arzneimittel (Pharmazeutisch) | USA | 1.6 Mrd. USD | - | - | 30.76 | 3.08 | ▲ 24.39% | ▲ 11.31% | - | - | - | -513.17% | ▼ -116.19% | -521.04% | ▼ -80.03% | -418.53% | ▼ -62.07% | 4 / 9 | 3,62 | −13,7-fach | 6 / 100 | −7,6 / 100 | −2,92 |
| Guizhou Bailing Group Pharmaceutical Co Ltd | 26.6 | Arzneimittel (Pharmazeutisch) | China | 0.9 Mrd. USD | - | - | 2.62 | 1.94 | ▼ -0.26% | - | - | ▲ 26.97% | - | -3.42% | ▼ -1.75% | 7.45% | ▼ -0.06% | 20.45% | ▲ 3.43% | 5 / 9 | 1,85 | −1,3-fach | 23 / 100 | −13,8 / 100 | −3,79 | |
![]() | Arcus Biosciences Inc | 26.6 | Arzneimittel (Biotechnologie) | USA | 2.4 Mrd. USD | - | - | 20.25 | 5.11 | ▲ 25.93% | ▲ 23.50% | - | - | - | -142.91% | ▼ -18.48% | -156.28% | ▼ -21.87% | -195.95% | ▼ -69.84% | 1 / 9 | −0,51 | −65,9-fach | 21 / 100 | 11,3 / 100 | −2,26 |
![]() | Celldex Therapeutics Inc | 26.5 | Arzneimittel (Biotechnologie) | USA | 2.3 Mrd. USD | - | - | 20796.30 | 3.26 | ▼ -27.36% | ▲ 34.05% | - | - | - | -17253.33% | ▼ -2895.78% | -19160.00% | ▼ -3314.63% | -14243.93% | ▼ -2361.13% | 4 / 9 | 2,23 | - | 0 / 100 | −8,2 / 100 | 0,75 |
| COSMO Pharmaceuticals SA | 26.5 | Arzneimittel (Pharmazeutisch) | Irland | 1.2 Mrd. USD | - | - | 10.69 | 1.94 | ▲ 11.46% | ▼ -14.51% | 3.27% | - | - | -3.44% | ▼ -4.04% | -10.00% | ▼ -2.58% | -15.12% | ▼ -0.95% | 2 / 9 | 7,50 | 18-fach | 8 / 100 | 1,3 / 100 | 0,11 | |
| Sichuan Biokin Pharmaceutical Co. Ltd. A | 26.4 | Arzneimittel (Pharmazeutisch) | China | 14.9 Mrd. USD | - | - | 154.95 | 21.56 | - | - | - | - | - | -41.81% | ▲ 4.53% | -29.50% | ▲ 6.47% | -42.15% | ▲ 7.07% | 3 / 9 | 6,40 | 17-fach | 20 / 100 | −2,2 / 100 | −3,11 | |
![]() | Sarepta Therapeutics Inc | 26.3 | Arzneimittel (Biotechnologie) | USA | 2.0 Mrd. USD | - | - | 1.03 | 1.34 | ▲ 32.41% | ▲ 5.18% | - | - | - | -32.45% | ▲ 14.22% | -29.92% | ▲ 14.01% | -13.99% | ▲ 12.91% | 3 / 9 | −2,77 | −18,2-fach | 39 / 100 | −15,2 / 100 | −3,35 |
![]() | Nektar Therapeutics | 26.0 | Arzneimittel (Pharmazeutisch) | USA | 1.3 Mrd. USD | - | - | 24.51 | 1.48 | ▼ -18.43% | ▼ -18.07% | - | - | - | -297.07% | ▲ 71.30% | -236.77% | ▲ 55.61% | -377.83% | ▲ 24.00% | 3 / 9 | −41,55 | −6,0-fach | 20 / 100 | 15,9 / 100 | −1,69 |
![]() | Stoke Therapeutics Inc | 26.0 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 61.77 | 4.93 | - | - | - | - | - | -3.73% | ▲ 614.71% | -11.16% | ▲ 627.93% | 24.35% | ▲ 463.98% | 5 / 9 | 5,51 | −7,9-fach | 44 / 100 | −12,5 / 100 | 2,33 |
![]() | Alector Inc | 25.8 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 18.12 | -25.20 | ▼ -0.05% | ▼ -4.82% | - | - | - | -679.16% | ▼ -134.99% | -692.83% | ▼ -139.06% | -874.66% | ▼ -224.61% | 3 / 9 | −9,55 | - | 4 / 100 | 14,0 / 100 | - |
| Shenzhen Hepalink Pharmaceutical Co Ltd | 25.8 | Arzneimittel (Pharmazeutisch) | China | 2.0 Mrd. USD | 65.66 | 41.64 | 2.54 | 1.12 | ▲ 0.55% | ▼ -19.35% | 1.57% | - | - | 6.38% | ▲ 0.73% | 11.61% | ▲ 1.41% | 29.05% | ▲ 11.59% | 6 / 9 | 5,81 | 1-fach | 11 / 100 | −8,2 / 100 | −2,77 | |
![]() | Idorsia Ltd | 25.7 | Arzneimittel (Biotechnologie) | Schweiz | 1.5 Mrd. USD | - | - | 6.10 | -1.02 | ▲ 25.23% | ▼ -24.15% | - | - | - | -50.54% | ▲ 410.75% | -59.28% | ▲ 397.04% | -75.59% | ▲ 394.23% | 4 / 9 | −25,39 | −5,3-fach | 39 / 100 | 8,9 / 100 | −1,78 |
![]() | Taysha Gene Therapies Inc | 25.6 | Arzneimittel (Biotechnologie) | USA | 1.4 Mrd. USD | - | - | 141.03 | 5.58 | - | - | - | - | - | -1115.27% | - | -1130.65% | - | -960.07% | - | 4 / 9 | −0,50 | −59,0-fach | 3 / 100 | −4,6 / 100 | - |
![]() | Abeona Therapeutics Inc | 25.6 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 10.20 | 2.03 | ▲ 14.19% | - | - | - | - | 1223.08% | ▲ 541.38% | -1536.91% | ▲ 20.24% | -1448.47% | ▼ -90.95% | 6 / 9 | −0,71 | −3,6-fach | 2 / 100 | 67,2 / 100 | 1,62 |
| Xiamen Kingdomway Group Co | 25.6 | Arzneimittel (Pharmazeutisch) | China | 1.6 Mrd. USD | 45.89 | - | 3.15 | 2.58 | ▼ -0.81% | ▼ -18.74% | 2.22% | ▼ -7.79% | 1 Jahre | 10.10% | ▼ -2.14% | 15.82% | ▼ -1.57% | 9.70% | ▼ -2.13% | 7 / 9 | 5,21 | 10-fach | 17 / 100 | −2,8 / 100 | −2,84 | |
![]() | Viatris Inc | 25.5 | Arzneimittel (Pharmazeutisch) | USA | 21.6 Mrd. USD | - | 11.51 | 1.46 | 1.51 | ▲ 3.66% | ▲ 39.31% | 2.56% | ▲ 1.76% | - | -24.58% | ▼ -5.21% | -18.62% | ▼ -4.67% | 13.55% | ▼ -0.30% | 5 / 9 | 0,45 | −1,6-fach | 13 / 100 | −15,7 / 100 | −3,33 |
| Shenzhen Hepalink Pharmaceutical | 25.4 | Arzneimittel (Pharmazeutisch) | China | 0.7 Mrd. USD | 14.45 | 3.41 | 0.92 | 0.41 | ▲ 0.55% | ▼ -19.35% | 4.21% | ▼ -1.60% | - | 6.38% | ▲ 0.73% | 11.61% | ▼ -0.29% | 29.05% | ▲ 11.58% | 6 / 9 | 5,45 | 1-fach | 11 / 100 | −8,2 / 100 | −2,79 | |
![]() | Verastem Inc | 25.3 | Arzneimittel (Biotechnologie) | USA | 1.2 Mrd. USD | - | - | 13.65 | 23.91 | ▲ 12.11% | ▲ 7.02% | - | - | - | -677.59% | ▲ 95.96% | -550.33% | ▲ 85.25% | -475.94% | ▲ 69.15% | 4 / 9 | −16,75 | −51,8-fach | 10 / 100 | −29,2 / 100 | 6,70 |
![]() | Ultragenyx | 25.2 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 2.37 | -5.83 | ▲ 19.95% | ▲ 25.25% | - | - | - | -85.44% | ▲ 18.06% | -79.49% | ▲ 14.12% | -70.13% | ▲ 16.38% | 4 / 9 | −9,54 | −8,1-fach | 37 / 100 | −7,1 / 100 | −2,66 |
![]() | 4D Molecular Therapeutics Inc | 25.2 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | - | - | 7.76 | 1.75 | ▲ 44.32% | ▲ 19.84% | - | - | - | -164.43% | ▼ -43111.97% | -187.24% | ▼ -50374.54% | -128.65% | ▼ -37022.64% | 5 / 9 | 7,19 | - | 14 / 100 | −5,5 / 100 | - |
![]() | Mesoblast Ltd | 25.2 | Arzneimittel (Biotechnologie) | Australien | 1.7 Mrd. USD | - | - | 14.46 | 3.06 | ▲ 74.54% | ▼ -10.18% | - | - | - | -47.82% | ▲ 219.13% | -42.64% | ▲ 205.36% | -37.03% | ▲ 177.19% | 6 / 9 | −0,89 | −2,7-fach | 13 / 100 | −1,8 / 100 | 2,49 |
| Changchun High & New Technology Industries Group Inc | 25.1 | Arzneimittel (Pharmazeutisch) | China | 4.4 Mrd. USD | - | - | 2.64 | 1.30 | ▲ 7.10% | ▼ -44.88% | 0.22% | ▼ -27.52% | - | 1.28% | ▼ -8.10% | 7.20% | ▼ -8.82% | -11.59% | ▼ -4.26% | 4 / 9 | 8,84 | > 50-fach | 36 / 100 | −2,4 / 100 | −3,49 |